SABS
SAB Biotherapeutics, Inc. Common Stock
stockNASDAQ
At CloseOct 2, 2026 3:59:54 PM EDT
2.97USD-2.941%(-0.09)416,319
Pre-marketOct 5, 2026 8:42:30 AM EDT
3.19USD+7.047%(+0.21)
Loading…
Loading…
270.68M
Healthcare
Biotechnology
HQ
Sioux Falls, SD, USA
Previous Close
$3.06
Beta
1.23
52-Week High
$5.15 2026-03-12
52-Week Low
$2.06 2025-10-06
SMA 50
$3.58
SMA 200
$3.78
Avg. Vol 10D
760,507
Avg. Vol 30D
507,772
Avg. Vol 90D
626,943
Relative Vol
0.82
90.99M
76.63M
84.22%
3,603,065
4.70%
13.37
55%/45%
69.97%
43.44%
5.1700%
1,300,000
2,043
27,297
99,801
Nov 13, 2026 (39d)
Jan 5, 2024 · 1-for-10 (reverse)
Sep 22, 2026
SABS Profile
sab biotherapeutics is a clinical-stage biopharmaceutical development company using its novel immunotherapy platform to produce life-saving therapies.
SABS Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 3.22 | 2026-09-28 | -7.46% | -2.177 |
| 1M | 3.72 | 2026-09-04 | -20.03% | 0.426 |
| 3M | 3.92 | 2026-07-06 | -24.11% | 1.232 |
| 6M | 3.85 | 2026-04-06 | -22.73% | 1.463 |
| 1Y | 2.29 | 2025-10-06 | +29.91% | 1.232 |
| 2Y | 2.62 | 2024-10-04 | +13.54% | — |
| 5Y | 100.75 | 2021-10-05 | -97.05% | 0.770 |
SABS Stock Summary
SAB Biotherapeutics, Inc. Common Stock (NASDAQ:SABS) stock price today is $2.98, and today's volume is 416,319. SABS is down 2.778% today. The 30 day average volume is 507,772. SABS market cap is $270.68M with 90.99M shares outstanding.